Skip to Main Content

Author Details

Dongqing Yan
Inner Mongolia University
2010
24
11
PMIDPaper TitleJournal TitlePublished Year
37265641Genomic insights into genetic diversity and local adaptation of a dominant desert steppe feather grass, <i>Stipa breviflora</i> Griseb.Front Plant Sci2023
34780648MS4A3 promotes differentiation in chronic myeloid leukemia by enhancing common β-chain cytokine receptor endocytosis.Blood2022
36536477Loss of G0/G1 switch gene 2 (G0S2) promotes disease progression and drug resistance in chronic myeloid leukaemia (CML) by disrupting glycerophospholipid metabolism.Clin Transl Med2022
33412552Femoral Heads from Total Hip Arthroplasty as a Source of Adult Hematopoietic Cells.Acta Haematol2021
34027418SIRT5 IS A DRUGGABLE METABOLIC VULNERABILITY IN ACUTE MYELOID LEUKEMIA.Blood Cancer Discov2021
32409689Dasatinib overcomes stroma-based resistance to the FLT3 inhibitor quizartinib using multiple mechanisms.Leukemia2020
31980730Coordinated inhibition of nuclear export and Bcr-Abl1 selectively targets chronic myeloid leukemia stem cells.Leukemia2020
33351838De novo assembly, annotation, marker discovery, and genetic diversity of the Stipa breviflora Griseb. (Poaceae) response to grazing.PLoS One2020
30563936Nuclear-Cytoplasmic Transport Is a Therapeutic Target in Myelofibrosis.Clin Cancer Res2019
31697804JAK2 ex13InDel drives oncogenic transformation and is associated with chronic eosinophilic leukemia and polycythemia vera.Blood2019
31648319The transcriptome of CMML monocytes is highly inflammatory and reflects leukemia-specific and age-related alterations.Blood Adv2019
31543464Combining the Allosteric Inhibitor Asciminib with Ponatinib Suppresses Emergence of and Restores Efficacy against Highly Resistant BCR-ABL1 Mutants.Cancer Cell2019
31540978ddeeper Than Deep: Can ddPCR Predict Successful Imatinib Cessation?Clin Cancer Res2019
28025836STAT3 mutations are not sufficient to induce large granular lymphocytic leukaemia in mice.Br J Haematol2018
29588547Ongoing clonal evolution in chronic myelomonocytic leukemia on hypomethylating agents: a computational perspective.Leukemia2018
29749399Autocrine Tnf signaling favors malignant cells in myelofibrosis in a Tnfr2-dependent fashion.Leukemia2018
27480386Rapid conversion of chronic myeloid leukemia to chronic myelomonocytic leukemia in a patient on imatinib therapy.Leukemia2016
26648538Age-related mutations and chronic myelomonocytic leukemia.Leukemia2016
26582647Extreme mutational selectivity of axitinib limits its potential use as a targeted therapeutic for BCR-ABL1-positive leukemia.Leukemia2016
26044284Deletion of Stat3 enhances myeloid cell expansion and increases the severity of myeloproliferative neoplasms in Jak2V617F knock-in mice.Leukemia2015
22144185Critical requirement for Stat5 in a mouse model of polycythemia vera.Blood2012
22837531Tyrosine 201 is required for constitutive activation of JAK2V617F and efficient induction of myeloproliferative disease in mice.Blood2012
21362419Differential biological activity of disease-associated JAK2 mutants.FEBS Lett2011
20197548Conditional expression of heterozygous or homozygous Jak2V617F from its endogenous promoter induces a polycythemia vera-like disease.Blood2010
  • 1 - 24 of 24

Recommended Authors

Oregon Health & Science University, Knight Cancer Institute
Career Start Year 2017
Number of shared co-authors 13
and Blood Institute, National Institutes of Health
Career Start Year 2013
Number of shared co-authors 0
National Cancer Institute, National Institutes of Health
Career Start Year 2013
Number of shared co-authors 0
Vanda Pharmaceuticals Inc.
Career Start Year 2010
Number of shared co-authors 0
Universite de Paris, Inserm CIC 1427
Career Start Year 2009
Number of shared co-authors 0
Knight Cancer Institute, Oregon Health & Science University
Career Start Year 2009
Number of shared co-authors 15
Sanford Burnham Prebys Medical Discovery Institute
Career Start Year 2009
Number of shared co-authors 0
Hospital Israelita Albert Einstein
Career Start Year 2007
Number of shared co-authors 0
NYU Robert I. Grossman School of Medicine
Career Start Year 2006
Number of shared co-authors 0
Graduate School of Medicine, The University of Tokyo
Career Start Year 2004
Number of shared co-authors 0
Adelaide Medical School, University of Adelaide
Career Start Year 2003
Number of shared co-authors 3
Universitatsklinikum Jena
Career Start Year 2002
Number of shared co-authors 3
Oregon Health & Science University
Career Start Year 2002
Number of shared co-authors 11
Washington University School of Medicine
Career Start Year 2001
Number of shared co-authors 13
St. Jude Children's Research Hospital
Career Start Year 2000
Number of shared co-authors 1
Oregon Health & Science University
Career Start Year 1998
Number of shared co-authors 14
Stanford University School of Medicine
Career Start Year 1998
Number of shared co-authors 4
University of California Irvine
Career Start Year 1998
Number of shared co-authors 9
Smilow Cancer Center, Yale University School of Medicine
Career Start Year 1997
Number of shared co-authors 1
University of Cambridge
Career Start Year 1996
Number of shared co-authors 2
Medical University of Vienna
Career Start Year 1995
Number of shared co-authors 2
Mayo Clinic
Career Start Year 1995
Number of shared co-authors 1
The University of Chicago
Career Start Year 1994
Number of shared co-authors 4
Washington University School of Medicine in St. Louis
Career Start Year 1994
Number of shared co-authors 1
Kyoto University
Career Start Year 1993
Number of shared co-authors 3
Hannover Medical School
Career Start Year 1993
Number of shared co-authors 2
Massachusetts General Hospital
Career Start Year 1993
Number of shared co-authors 3
James P. Wilmot Cancer Institute, University of Rochester Medical Center Rochester
Career Start Year 1992
Number of shared co-authors 2
Knight Cancer Institute, Oregon Health & Science University
Career Start Year 1991
Number of shared co-authors 14
The University of Tokyo.
Career Start Year 1984
Number of shared co-authors 0

Collaborators

University of Utah Huntsman Cancer Institute
Co-authored papers 15
Huntsman Cancer Institute, University of Utah
Co-authored papers 15
Huntsman Cancer Institute, University of Utah
Co-authored papers 13
Huntsman Cancer Institute, The University of Utah
Co-authored papers 8
Texas Tech University Health Sciences Center at El Paso
Co-authored papers 8
Huntsman Cancer Institute, The University of Utah
Co-authored papers 7
Institute of Cancer Research
Co-authored papers 7
Singapore General Hospital
Co-authored papers 6
Huntsman Cancer Institute, The University of Utah
Co-authored papers 6
Oregon Health & Science University
Co-authored papers 5
Huntsman Cancer Institute at the University of Utah.
Co-authored papers 5
University of Utah
Co-authored papers 5
University of Utah
Co-authored papers 4
Huntsman Cancer Institute, The University of Utah
Co-authored papers 3
Oregon Health & Science University School of Medicine
Co-authored papers 3
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 3
Huntsman Cancer Institute, The University of Utah
Co-authored papers 2
Huntsman Cancer Institute
Co-authored papers 2
University of Utah
Co-authored papers 1
The University of Utah
Co-authored papers 1
Astex Pharmaceuticals
Co-authored papers 1
Stanford University School of Medicine
Co-authored papers 1
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 1
Yonsei University College of Medicine, Republic of Korea S. Biomedics Co.
Co-authored papers 1
Oregon Health & Science University, University of California Berkeley
Co-authored papers 1
University of Colorado Anschutz Medical Campus
Co-authored papers 1
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 1
Fred Hutchinson Cancer Center
Co-authored papers 1
University of Alabama at Birmingham, USA O'Neal Comprehensive Cancer Center
Co-authored papers 1
Fred Hutchinson Cancer Center
Co-authored papers 1